Radiation Therapy For Oropharyngeal Squamous Cell Carcinoma
Publication Date: August 1, 2017
Last Updated: March 14, 2022
Recommendations
When is it appropriate to add systemic therapy to definitive RT in the treatment of OPSCC?
In the scenario of stage IVA-B disease?
Concurrent high-dose intermittent cisplatin should be delivered to patients with stage IVA-B OPSCC receiving definitive RT. (Strong, High)
323259
Title
Radiation Therapy For Oropharyngeal Squamous Cell Carcinoma
Authoring Organization
American Society for Radiation Oncology